期刊文献+

汇聚征与乳腺浸润性导管癌临床病理特征的相关性 被引量:7

Correlation between clinicopathological characteristics and convergence symptom in patients with breast infiltrating ductal carcinoma
原文传递
导出
摘要 目的 探讨自动乳腺全容积扫描(automated breast volume scanner,ABVS)冠状面汇聚征对乳腺浸润性导管癌(infiltrating ductal carcinoma,IDC)治疗敏感性及其预后的预测价值.方法 选取于本院行乳腺癌根治性切除术、病理诊断为IDC的患者46例,共47个病灶,分析病灶ABVS冠状面汇聚征与其临床病理[病灶大小、病理组织学分级、腋窝淋巴结状态以及雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体(HER2)表达]的相关性.结果 汇聚征在不同大小和不同腋窝淋巴结状态IDC组中出现比例差异无统计学意义(P>0.05).汇聚征在病理分级Ⅱ级组中出现的比例高于Ⅲ级组,差异有统计学意义(P=0.008).汇聚征在ER阳性组出现的比例高于ER阴性组,但差异无统计学意义(P=0.055);在PR阳性组出现的比例高于PR阴性组,差异有统计学意义(P=0.004);在HER2阴性组出现的比例高于HER2阳性组,差异有统计学意义(P=0.019).结论 汇聚征对IDC治疗敏感性及其预后有一定的预测价值. Objective To explore the value of convergence symptom in predicting the treatment sensitivity and the prognosis of patients with breast infiltrating ductal carcinoma (IDC).Methods A retrospective review was performed in 46 women with 47 IDC lesions.Correlation between clinicopathological characteristics and convergence symptom was analyzed.Clinicopathological characteristics included tumor size,tumor grade,axillary lymph node state and the expression of ER,PR and H ER2.Results There was no obvious difference within different IDC groups by tumor size or axillary lymph node state in the presentation of convergence symptom (P > 0.05).The convergence symptom was more common in grade Ⅱ IDC lesions than in grade Ⅲ IDC lesions and the difference was statistically significant (P =0.008).No difference was found between the presentation of convergence symptom and the expression of ER (P =0.055).Significant correlations were found between the presentation of convergence symptom and the expression of PR and HER2 (P <0.05).Conclusions Convergence symptom is helpful in predicting the treatment sensitivity and the prognosis of patients with breast infiltrating ductal carcinoma.
出处 《中华超声影像学杂志》 CSCD 北大核心 2014年第12期1057-1060,共4页 Chinese Journal of Ultrasonography
基金 国家自然科学基金(81371577)
关键词 超声检查 导管 乳腺 汇聚征 Ultrasonography,mammary Carcinoma,ductal,breast Convergence symptom
  • 相关文献

参考文献17

二级参考文献82

共引文献180

同被引文献50

  • 1Wang Y, Ikeda DM, Narasimhan B, et al. Estrogen receptor- negative invasive breast cancer : imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression[J].Radiology, 2008, 246 ( 2 ) : 367-375. DOI : 10. 1148/radiol. 2462070169.
  • 2Zhang L, Li J, Xiao Y, et al. Identifying ultrasound and clinical features of breast cancer molecular subtypes by ensemble decision[J].Sci Rep, 2015,5 : 11085. DOI : 10.1038/srepl 1085.
  • 3Kotsianos-Hermle D, Hihawsky KM, Wirth S, et al. Analysis of 107 breast lesions with automated 3D ultrasound and comparison with mammography and manual ultrasound [J]. Eur J Radiol, 2009,71(1) :109-115.DOI:10. 1016/j. ejrad.2008.04.001.
  • 4Chen L, Chen Y, Diao XH, et al. Comparative study of automated breast 3-D ultrasound and handheld B-mode ultrasound for differentiation of benign and malignant breast masses [J]. Ultrasound Med Biol, 20 13,39 (10) : 1735-1742. DOI : l 0.1016/j. ultrasmedbio. 2013.04. 003.
  • 5Zheng FY, Yan LX, Huang BJ, et al. Comparison of retraction phenomenon and BI-RADS-US descriptors in differentiating benign and malignant breast masses using an automated breast volume scanner [J]. Eur J Radiol, 2015,84 ( 11 ) : 2123-2129. DOI : 10. 1016/j. ejrad. 2015.07. 028.
  • 6Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Ontology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer[J]. Arch Pathol Lab Med, 2010, 134 (6):907-922. DOI: 10. 1043/1543-2165 134. 6. 907.
  • 7Bartlett JM, Starezynski J, Atkey N, et al. HER2 testing in the UK:recommendations for breast and gastric in-situ hybridisation methods [J]. J Clin Pathol, 2011,64 (8) : 649-653. DOI : 10.1136/ iep. 2011. 089847.
  • 8Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 [J]. Ann Oneol, 2011,22 (8) : 1736-1747. DOI: 10. 1093/annonc/mdr304.
  • 9Chang CY, Kuo SJ, Wu HK, et al. Stellate masses and histologic grades in breast cancer[J]. Ultrasound Med Biol, 2014, 40(5): 904-916. DOI : 10.1016/j. ultrasmedbio. 2013.11. 006.
  • 10Engstrom MJ, Opdahl S, Hagen AI, et al. Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients[J]. Breast Cancer Res Treat, 2013, 140(3):463- 473. DOI: 10. 1007/s10549-013-2647-2.

引证文献7

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部